Opportunity ID: 334367

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-ES-21-006
Funding Opportunity Title: CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Environment
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.113 — Environmental Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 25, 2021
Last Updated Date: Jun 25, 2021
Original Closing Date for Applications: Sep 20, 2023
Current Closing Date for Applications: Sep 20, 2023
Archive Date: Oct 26, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
County governments
State governments
City or township governments
Native American tribal governments (Federally recognized)
Private institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support research seeking to understand mechanisms of chemical toxicity and to identify potential molecular/genetic targets that reduce acute effects of chemical threat agents that affect the eyes and lungs. These discoveries can lead to exploration of therapeutic countermeasures through early stage development efforts supported by the Countermeasures Against Chemical Threats (CounterACT) NIH-wide program, a component within the Chemical Countermeasures Research Program (CCRP).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-21-006.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 334367 Full Announcement-RFA-ES-21-006 -> RFA-ES-21-006-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00269869 Oct 28, 2021 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00267906 Sep 14, 2021 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277870 Nov 01, 2022 Sep 20, 2023 View

Package 1

Mandatory forms

334367 RR_SF424_5_0-5.0.pdf

334367 PHS398_CoverPageSupplement_5_0-5.0.pdf

334367 RR_OtherProjectInfo_1_4-1.4.pdf

334367 PerformanceSite_4_0-4.0.pdf

334367 RR_KeyPersonExpanded_4_0-4.0.pdf

334367 PHS398_ResearchPlan_4_0-4.0.pdf

334367 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334367 RR_Budget_3_0-3.0.pdf

334367 RR_SubawardBudget30_3_0-3.0.pdf

334367 PHS398_ModularBudget_1_2-1.2.pdf

334367 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

334367 RR_SF424_2_0-2.0.pdf

334367 PHS398_CoverPageSupplement_5_0-5.0.pdf

334367 RR_OtherProjectInfo_1_4-1.4.pdf

334367 PerformanceSite_2_0-2.0.pdf

334367 RR_KeyPersonExpanded_2_0-2.0.pdf

334367 PHS398_ResearchPlan_4_0-4.0.pdf

334367 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334367 RR_Budget_1_4-1.4.pdf

334367 RR_SubawardBudget30_1_4-1.4.pdf

334367 PHS398_ModularBudget_1_2-1.2.pdf

334367 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

334367 RR_SF424_5_0-5.0.pdf

334367 PHS398_CoverPageSupplement_5_0-5.0.pdf

334367 RR_OtherProjectInfo_1_4-1.4.pdf

334367 PerformanceSite_4_0-4.0.pdf

334367 RR_KeyPersonExpanded_4_0-4.0.pdf

334367 PHS398_ResearchPlan_5_0-5.0.pdf

334367 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334367 RR_Budget_3_0-3.0.pdf

334367 RR_SubawardBudget30_3_0-3.0.pdf

334367 PHS398_ModularBudget_1_2-1.2.pdf

334367 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T12:51:32-05:00

Share This Post, Choose Your Platform!

About the Author: